Literature DB >> 11124036

Structure-activity relationships in a peptidic alpha7 nicotinic acetylcholine receptor antagonist.

J P Rogers1, P Luginbühl, K Pemberton, P Harty, D E Wemmer, R C Stevens.   

Abstract

alpha-Conotoxins are small disulfide-constrained peptide toxins which act as antagonists at specific subtypes of nicotinic acetylcholine receptors (nACh receptors). In this study, we analyzed the structures and activities of three mutants of alpha-conotoxin ImI, a 12 amino acid peptide active at alpha7 nACh receptors, in order to gain insight into the primary and tertiary structural requirements of neuronal alpha-conotoxin specificity. NMR solution structures were determined for mutants R11E, R7L, and D5N, resulting in representative ensembles of 20 conformers with average pairwise RMSD values of 0.46, 0.52, and 0.62 A from their mean structures, respectively, for the backbone atoms N, C(alpha), and C' of residues 2-11. The R11E mutant was found to have activity near that of wild-type ImI, while R7L and D5N demonstrated activities reduced by at least two orders of magnitude. Comparison of the structures reveals a common two-loop architecture, with variations observed in backbone and side-chain dihedral angles as well as surface electrostatic potentials upon mutation. Correlation of these structures and activities with those from previously published studies emphasizes that existing hypotheses regarding the molecular determinants of alpha-conotoxin specificity are not adequate for explaining peptide activity, and suggests that more subtle features, visualized here at the atomic level, are important for receptor binding. These data, in conjunction with reported characterizations of the acetylcholine binding site, support a model of toxin activity in which a single solvent-accessible toxin side-chain anchors the complex, with supporting weak interactions determining both the efficacy and the subtype specificity of the inhibitory activity. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11124036     DOI: 10.1006/jmbi.2000.4247

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  9 in total

1.  A comparative study on selectivity of alpha-conotoxins GI and ImI using their synthetic analogues and derivatives.

Authors:  Igor E Kasheverov; Maxim N Zhmak; Innokenty V Maslennikov; Yuri N Utkin; Victor I Tsetlin
Journal:  Neurochem Res       Date:  2003-04       Impact factor: 3.996

2.  Structural determinants of selective alpha-conotoxin binding to a nicotinic acetylcholine receptor homolog AChBP.

Authors:  Chris Ulens; Ronald C Hogg; Patrick H Celie; Daniel Bertrand; Victor Tsetlin; August B Smit; Titia K Sixma
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-27       Impact factor: 11.205

3.  Inhibition of cholinergic pathways in Drosophila melanogaster by α-conotoxins.

Authors:  Mari D Heghinian; Monica Mejia; David J Adams; Tanja A Godenschwege; Frank Marí
Journal:  FASEB J       Date:  2014-12-02       Impact factor: 5.191

4.  A synthetic combinatorial strategy for developing alpha-conotoxin analogs as potent alpha7 nicotinic acetylcholine receptor antagonists.

Authors:  Christopher J Armishaw; Narender Singh; Jose L Medina-Franco; Richard J Clark; Krystle C M Scott; Richard A Houghten; Anders A Jensen
Journal:  J Biol Chem       Date:  2009-11-09       Impact factor: 5.157

5.  Acetylcholine promotes binding of α-conotoxin MII at α3 β2 nicotinic acetylcholine receptors.

Authors:  Somisetti V Sambasivarao; Jessica Roberts; Vivek S Bharadwaj; Jason G Slingsby; Conrad Rohleder; Chris Mallory; James R Groome; Owen M McDougal; C Mark Maupin
Journal:  Chembiochem       Date:  2014-01-13       Impact factor: 3.164

6.  Blockade of neuronal α7-nAChR by α-conotoxin ImI explained by computational scanning and energy calculations.

Authors:  Rilei Yu; David J Craik; Quentin Kaas
Journal:  PLoS Comput Biol       Date:  2011-03-03       Impact factor: 4.475

Review 7.  Synthetic α-conotoxin mutants as probes for studying nicotinic acetylcholine receptors and in the development of novel drug leads.

Authors:  Christopher J Armishaw
Journal:  Toxins (Basel)       Date:  2010-06-14       Impact factor: 4.546

Review 8.  Mutagenesis of α-Conotoxins for Enhancing Activity and Selectivity for Nicotinic Acetylcholine Receptors.

Authors:  Matthew W Turner; Leanna A Marquart; Paul D Phillips; Owen M McDougal
Journal:  Toxins (Basel)       Date:  2019-02-13       Impact factor: 4.546

Review 9.  Structure-Function of Neuronal Nicotinic Acetylcholine Receptor Inhibitors Derived From Natural Toxins.

Authors:  Thao N T Ho; Nikita Abraham; Richard J Lewis
Journal:  Front Neurosci       Date:  2020-11-25       Impact factor: 4.677

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.